ストックスクリーナーアプリを入手
1.15
0.00%
0.00
前日終値:
$1.15
開ける：
$1.15
24時間の取引高:
82,341
Relative Volume:
0.32
時価総額：
$70.07M
収益：
$33.79M
当期純損益:
$-18.67M
株価収益率:
-3.2105
EPS:
-0.3582
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
-11.54%
1か月 パフォーマンス:
+10.58%
6か月 パフォーマンス:
+8.49%
1年 パフォーマンス:
+15.00%
1日の値動き範囲:
$1.10
$1.18
1週間の範囲:
$1.06
$1.32
52週間の値動き範囲:
$0.70
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
CTSO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.15 | 70.07M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
Cytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short Interest - Defense World
B. Riley Securities initates Cytosorbents Corp (CTSO) rating to a Buy - Knox Daily
CTSO stock touches 52-week high at $1.6 amid robust annual growth - MSN
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat
Sargent Investment Group LLC Sells 377,384 Shares of Cytosorbents Co. (NASDAQ:CTSO) - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vanguard Group Inc's Strategic Acquisition of CytoSorbents Corp Shares - GuruFocus.com
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Chief Medical Officer Deliargyris Efthymios exercised 16,233 in-the-money shares at a strike of $1.00, increasing direct ownership by 4% to 403,025 units (SEC Form 4) - Quantisnow
CytoSorbents Strengthens Balance Sheet with Successful Conclusion of Rights Offering - Defense World
Cytosorbents Boosts Liquidity with Successful Rights Offering - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
CytoSorbents closes oversubscribed rights offering - MSN
D. Boral Capital Reiterates Buy Rating for Cytosorbents (NASDAQ:CTSO) - MarketBeat
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts - Benzinga
CytoSorbents Raises $6.25M in Oversubscribed Rights Offering, Unlocks $5M Restricted Cash - StockTitan
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering - GlobeNewswire
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Stake Boosted by Geode Capital Management LLC - Defense World
Skylands Capital, LLC Increases Stake in CytoSorbents Corp - GuruFocus.com
Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports
CytoSorbents opens new sales subsidiary in Dubai - Investing.com
CytoSorbents Expands Global Reach with Strategic Dubai Hub for Middle East & Africa Growth - StockTitan
CytoSorbents reported strong Q4 results, says D. Boral Capital - Yahoo Finance
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth - Benzinga
Cytosorbents' (CTSO) Buy Rating Reiterated at D. Boral Capital - MarketBeat
CytoSorbents reports revenue growth in Q4 - Investing.com
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - Quantisnow
Comparing Cytosorbents (NASDAQ:CTSO) & Presbia (OTCMKTS:LENSF) - Defense World
CytoSorbents begins rights offering for stockholders - Investing.com
CytoSorbents Launches $1.00 Rights Offering with Discounted Warrant Package for Shareholders - StockTitan
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
Peter J. Mariani Purchases 20,000 Shares of Cytosorbents Co. (NASDAQ:CTSO) Stock - MarketBeat
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock - Investing.com India
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock By Investing.com - Investing.com Nigeria
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Update - MarketBeat
Cytosorbents CFO Peter Mariani buys $27,974 in stock - Investing.com
KORU Medical Systems (NASDAQ:KRMD) and Cytosorbents (NASDAQ:CTSO) Head-To-Head Comparison - Defense World
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):